# Provectus Biopharmaceuticals, Inc.: Form SC 13D/A, filed Dec 6, 2024

- Company: [Provectus Biopharmaceuticals, Inc.](/companies/pvct.md) (CIK 315545)
- Form: SC 13D/A
- Filed: 2024-12-06
- Accepted by EDGAR: Dec 6, 2024, 19:45 ET
- Period: not reported
- Accession: 0001493152-24-049162
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/315545/000149315224049162/formsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/315545/000149315224049162/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/315545/000149315224049162/formsc13da.htm

Filed Dec 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-049162. Last ingested by Listed: Oct 30, 2026, 11:33 ET. No prices; not investment advice.